Caris Life Sciences Inc - Class A
Research Caris Life Sciences Inc - Class A (CAI) on Bullrun: market cap USD 7.92B, P/E 75.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCAI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 7.92B
- P/E75.2
- Financial periodQ2 2026
- RevenueUSD 263.71M
- Net income-USD 637.00K
- Free cash flowUSD 6.40M
- Gross margin68.1%
Valuation Snapshot
latest market cap is USD 7.92B; P/E is 75.2.
Peer valuation comparison
Latest P/E is 75.24x versus a Healthcare sector median of 24.46x (207.6% above).
Latest P/E is 75.24x versus a United States median of 24.87x (202.6% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 812.03M | -USD 68.09M | USD 66.90M | 66.4% | -3.22 | USD 796.27M | USD 378.99M | USD 577.31M |
| FY2024 | USD 412.26M | -USD 281.89M | -USD 253.64M | n/a | -10.66 | USD 63.95M | USD 379.53M | -USD 2.50B |
| FY2023 | USD 306.13M | -USD 341.42M | -USD 298.42M | n/a | -13.24 | n/a | n/a | -USD 2.14B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 7.92B | 75.2 | n/a | n/a |
| 2025 | 2025-12-31 | USD 7.61B | n/a | n/a | n/a |
About Caris Life Sciences Inc - Class A
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Caris Life Sciences Inc - Class A's market cap?
Caris Life Sciences Inc - Class A's market capitalization is USD 7.92B.
What is Caris Life Sciences Inc - Class A's P/E ratio?
Caris Life Sciences Inc - Class A's price-to-earnings (P/E) ratio is 75.2.
What does Caris Life Sciences Inc - Class A do?
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms.